Bin Sabbar, N.S., Alowirdi, F.S., Basakran, F.A., Al-Badr, L.A., Assiri, R.A., Alshahrani, W.A., Althubaiti, A. and Damlaj, M. 2019. Addition of rituximab to hyper-CVAD improves overall survival in newly diagnosed Burkitt leukemia/lymphoma from the Middle East and North Africa region. International Journal Of Community Medicine And Public Health. 6, 10 (Sep. 2019), 4199–4203. DOI:https://doi.org/10.18203/2394-6040.ijcmph20194475.